An effective, affordable, and accessible HIV vaccine is 7-10 years away, according to scientists at the Medical Research Council of South Africa, in this week’s BMJ. However, its success depends on a complex interplay of politics, science, and public-private partnerships.
Equitable public-private partnerships between researchers, manufacturers, and distributors and partnerships between rich and poor countries are the best strategy for the development of the vaccine, say the authors. Successful vaccine development also entails adequate investment in the countries that carry the burden of the HIV/AIDS pandemic.
Vaccines are the only hope for the control and possible elimination of HIV infection. How we distribute the vaccine will also be a test of our international ethics and humanitarian objectives, they write.
If we fail to provide the world with an effective HIV vaccine, future generations will judge us harshly, because this failure will not be due to lack of ability or resources but to politics, they conclude.
Emma Wilkinson | Source: alphagalileo
More articles from
Health and Medicine:
Mayo Clinic study shows stool DNA testing for colorectal cancer has potential, but challenges remain
07.10.2008 | Mayo Clinic
Patients who recover from coma but cannot communicate feel pain
07.10.2008 | University of Liège
Study finds genetic variant plays role in cleft lip
07.10.2008 | Life Sciences
Portable imaging system will help maximize public health response to natural disasters
07.10.2008 | Ecology, The Environment and Conservation
Researchers reveal Epstein-Barr virus protein contributes to cancer
07.10.2008 | Life Sciences